Crossref
Patient-reported tolerability: insights from a secondary analysis of the LIBRETTO-531 study
Annals of Thyroid · 2026-07 · 11 · 13-13
DOI: 10.21037/aot-2026-0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Thyroid, 2026-07. Verfasst von Amirbahador Golchin und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Golchin, A., & Meister, K. (2026). Patient-reported tolerability: insights from a secondary analysis of the LIBRETTO-531 study. Annals of Thyroid, 11, 13-13. https://doi.org/10.21037/aot-2026-0015
Vancouver
Golchin A, Meister K. Patient-reported tolerability: insights from a secondary analysis of the LIBRETTO-531 study. Annals of Thyroid. 2026;11:13-13. doi:10.21037/aot-2026-0015
BibTeX
@article{Golchin2026,
author = {Golchin, Amirbahador and Meister, Kara},
title = {Patient-reported tolerability: insights from a secondary analysis of the LIBRETTO-531 study},
journal = {Annals of Thyroid},
year = {2026},
volume = {11},
pages = {13--13},
doi = {10.21037/aot-2026-0015}
}
EUVIMED